Skip to content

Publications, events, virus pictures...

Latest news

March 2024, NeoVirTech obtains funding from the AAP France 2030 to develop innovative theranostic platform for cancer virotherapies

2 avril 2024 |
NeoVirTech obtains funding from the AAP France 2030 to develop innovative theranostic platform for cancer virotherapies. NeoVirTech, in partnership with Imactiv-3D, the ImPACT team from the Cancer Research Center of
READ MORE

February 2024, NeoVirTech celebrates its 10 years of activity.

2 février 2024 |
February 2024, NeoVirTech celebrates its 10 years of activity. We are extremely proud to announce that NeoVirTech celebrate its 10 years of activity today. We want to thanks all the
READ MORE

Picture of the month, January 2024: The pace speeds up!

19 janvier 2024 |
Picture of the Month, January 2024: The pace speeds up! In the New Year, we’ll be putting out more of our ANCHOR viruses to answer all your questions! Whether you’re
READ MORE

Picture of the month, may 2023: High throughput imaging and quantification of human respiratory epithelium infected with SARS-CoV-2 Omicron.

15 mai 2023 |
Picture of the Month, May 2023: High throughput imaging and quantification of human respiratory epithelium infected with SARS-CoV-2 Omicron. This picture shows reconstructed human airway epithelium (MucilAir, epithelix) infected with
READ MORE

NeoVirTech SAS and VirexpR SAS create a strategical alliance to combine NeoVirTech’s autofluorescent viruses with VirexpR nebulization technologies for airborne disinfection testing.

27 février 2023 |
NeoVirTech SAS and VirexpR SAS create a strategical alliance to combine NeoVirTech’s autofluorescent viruses with VirexpR nebulization technologies for airborne disinfection testing. What if we could combine our autofluorescent viruses
READ MORE
LOAD MORE